Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
This report contains market size and forecasts of Biologics in Spine Surgery in global, including the following market information:
Global Biologics in Spine Surgery Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Biologics in Spine Surgery Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Biologics in Spine Surgery companies in 2021 (%)
The global Biologics in Spine Surgery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bone Graft Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biologics in Spine Surgery include Medtronic, J &J (DePuy Synthes), SeaSpine, Xtant Medical, Zimmer Biomet, Stryker, Straumann, Wright Medical Group and Hans Biomed and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biologics in Spine Surgery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biologics in Spine Surgery Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Biologics in Spine Surgery Market Segment Percentages, by Type, 2021 (%)
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
Other
Global Biologics in Spine Surgery Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Biologics in Spine Surgery Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Other
Global Biologics in Spine Surgery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Biologics in Spine Surgery Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biologics in Spine Surgery revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Biologics in Spine Surgery revenues share in global market, 2021 (%)
Key companies Biologics in Spine Surgery sales in global market, 2017-2022 (Estimated), (Units)
Key companies Biologics in Spine Surgery sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
J &J (DePuy Synthes)
SeaSpine
Xtant Medical
Zimmer Biomet
Stryker
Straumann
Wright Medical Group
Hans Biomed
Arthrex